We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Vicotex

Download Mobile App




Reference Ranges Established for Automated Cerebrospinal Fluid Cell Count

By LabMedica International staff writers
Posted on 11 Feb 2014
Cerebrospinal fluid (CSF) cell count is an important analysis in the investigation of central nervous system (CNS) infections, and new reference ranges for leukocytes in the CSF have been established. More...


The references ranges for granulocytes, lymphocytes, and monocytes in the CSF were originally based on manual counts, but since the introduction of automated cell counters, these ranges have not been revised, or abnormalities connected to diseases.

Infectious disease specialists at the Sahlgrenska Academy (Gothenburg, Sweden) analyzed CSF from 80 neurologically healthy volunteers. For the differential diagnosis section, they analyzed cell counts and hospital records from 175 patients with CSF mononuclear pleocytosis, which is an increased cell count particularly an increase in white blood cell (WBC) count, in a bodily fluid, such as CSF.

Manual CSF cell counting was performed and compared with automated CSF cell counting was performed on a ADVIA 2120i instrument within one hour of sampling using the ADVIA 2120i CSF Assay (Siemens, Erlangen, Germany). The method requires 300 μL of CSF and reports counts for erythrocytes, lymphocytes, monocytes and granulocytes, which are differentiated on the basis of size, absorbance and light scattering characteristics.

Correlation between manual and automated cell counts was excellent for erythrocytes, but was lower for leukocytes, when erythrocyte counts were lower than 250 cells/μL. For the neurologically healthy volunteers studied in the reference range section, the 95th percentile was 3.0 cells/μL for lymphocytes, 1.0 cell/μL for monocytes, and 1.0 cell/μL for granulocytes. In the differential diagnosis section, comparisons were done between the groups with Lyme neuroborreliosis and viral CNS infection. There were no significant differences between these two groups regarding cell counts; neither for lymphocytes, median 58 cells/μL vs. 72 cells/μL; nor for monocytes, median 13 cells/μL vs. 16 cells/μL; nor for granulocytes, median 1 cell/μL vs. 2 cells/μL.

The authors suggested that new reference ranges of less than 4 cells/μL for lymphocytes, less than 3 cells/μL for monocytes, and less than 3 cells/μL for granulocytes for CSF leukocytes when automatically analyzed with the Siemens ADVIA 2120i. The separation of mononuclear cells into lymphocytes and monocytes did not facilitate the discrimination between Lyme neuroborreliosis and viral CNS infection. The study was published in the January 2014 issue of the journal Clinical Biochemistry.

Related Links:

Sahlgrenska Academy
Siemens 



Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
New
Gold Member
Serum Indices Control
Acusera Serum Indices Control
Manual Pipetting Aid
Pipette Controllers macro
New
Portable POCT Blood Gas Analyzer
BD100
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The Avantect Pancreatic Cancer Test combines epigenomic, genomic, and glycan biomarkers with machine learning to detect pancreatic cancer-associated signals in blood (Photo courtesy of ClearNote Health)

Multiomic Blood Test Supports Noninvasive Monitoring and Subtyping in Pancreatic Cancer

Pancreatic ductal adenocarcinoma remains difficult to detect early and monitor during treatment, particularly in patients with homologous recombination defects. Clinicians also have limited noninvasive... Read more

Immunology

view channel
Image: Although many people harbor latent Epstein-Barr virus (EBV), growing evidence has linked the virus to MS pathobiology (Image Credit: Adobe Stock)

Blood EBV Activity Biomarkers May Predict Multiple Sclerosis Relapse Months Ahead

Predicting relapse in multiple sclerosis (MS) remains difficult, limiting opportunities for timely intervention and monitoring. Although many people harbor latent Epstein-Barr virus (EBV), growing evidence... Read more

Microbiology

view channel
Image: Graphical Abstract (Jose A. Céspedes, Maria I. Montañez, Isabel M. Jiménez, et al. Magnetic nanoparticles enable clinically relevant in vitro diagnosis of beta-lactam allergy. Materials Today Bio (2026). DOI: 10.1016/j.mtbio.2026.103356)

Magnetic Nanoparticles Enable More Sensitive Beta-Lactam Allergy Testing

Penicillin allergy labels are common in clinical practice, yet many are incorrect and can lead to suboptimal antibiotic choices. Although 8%–25% of people report a penicillin allergy, only 1%–10% are truly... Read more

Pathology

view channel
Image: A new study demonstrates that vascular features in colorectal tumors could serve as prognostic biomarkers of disease outcome. (Image Credit: iStock)

Tumor Blood Vessel Features May Help Predict Colorectal Cancer Survival

Colorectal cancer outcomes vary widely, and tumor biology remains a key determinant of prognosis. Because neoplasms depend on a vascular supply, differences in intratumoral vessels may influence survival.... Read more

Technology

view channel
Image: ADLM recommends that emerging AI tools follow the same professional oversight, quality, validation, and monitoring standards as traditional clinical testing within CLIA’s existing framework (Image Credit: Adobe Stock)

ADLM Calls for CLIA Updates to Support Safe AI Use in Laboratory Medicine

Clinical laboratories increasingly use artificial intelligence to verify, interpret, and report results, but safeguards under the Clinical Laboratory Improvement Amendments (CLIA) were designed in 1992.... Read more

Industry

view channel
Image Credit: Adobe Stock

Mayo Clinic and Thermo Fisher Launch Multi-Omics Venture to Identify Early Disease Signals

Many diseases begin developing years before symptoms emerge, making early detection difficult for healthcare systems and clinical laboratories. Linking molecular changes with longitudinal health data could... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.